Trump DOJ moves to dismiss lawsuit challenging FDA's approval of abortion pill mifepristone, citing procedural issues rather than merits of the drug's approval.
Trump DOJ moves to dismiss lawsuit challenging FDA's approval of abortion pill mifepristone, citing procedural issues rather than merits of the drug's approval.